Integrin Receptor Antagonists

Integrin Receptor Antagonist

Colitis, Ulcerative

Crohn Disease

Enteritis

<section class="Section" data-sectioncode="34089-3"><a name="S11"></a><a name="section-9"></a><p></p><h1>11 DESCRIPTION</h1><p class="First">Vedolizumab, an integrin receptor antagonist, is a humanized IgG<span class="Sub">1 </span>monoclonal antibody produced in Chinese hamster ovary cells that binds to the human α4β7 integrin. ENTYVIO has an approximate molecular weight of 147 kilodaltons.</p><div class="Section" data-sectioncode="42229-5"><a name="section-9.1"></a><p></p><p class="First"><span class="Italics Underline">Intravenous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) for injection is supplied as a sterile, white to off-white, preservative-free, lyophilized cake for intravenous infusion. After reconstitution with 4.8 mL Sterile Water for Injection, USP, 0.9% Sodium Chloride Injection, USP, or Lactated Ringer's Injection, USP, the resulting concentration is 60 mg/mL with a deliverable volume of 5 mL (300 mg) and the resulting pH is approximately 6.3.</p><p>Each single-dose vial contains 300 mg vedolizumab, arginine hydrochloride (131.7 mg), histidine (23 mg), histidine monohydrochloride (21.4 mg), polysorbate 80 (3 mg), and sucrose (500 mg).</p></div><div class="Section" data-sectioncode="42229-5"><a name="section-9.2"></a><p></p><p class="First"><span class="Italics Underline">Subcutaneous ENTYVIO</span></p><p>ENTYVIO (vedolizumab) injection is supplied as a sterile, clear to moderately opalescent, colorless to slightly yellow, preservative-free solution for subcutaneous administration.</p><p>Each single-dose prefilled syringe or single-dose prefilled pen (ENTYVIO PEN) contains 108 mg vedolizumab, arginine hydrochloride (17.77 mg), citric acid monohydrate (0.18 mg), histidine (3.86 mg), histidine monohydrochloride (1.86 mg), polysorbate 80 (1.35 mg), sodium citrate dihydrate (4.71 mg) and Sterile Water for Injection, USP, at a pH of 6.5.</p></div></section>

Entyvio

vedolizumab

vedolizumab 300 MG Injection

vedolizumab 300 MG Injection [Entyvio]

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe

0.68 ML vedolizumab 159 MG/ML Prefilled Syringe [Entyvio]

0.68 ML vedolizumab 159 MG/ML Auto-Injector

0.68 ML vedolizumab 159 MG/ML Auto-Injector [Entyvio]

SSM Health Specialty PharmacyLumicera

Afinitor

Afinitor Disperz

Alecensa

Aliqopa

Alunbrig

Avastin

Ayvakit

Beleodaq

Besponsa

Blinctyo

Bosulif

Braftovi

Cabometyx

Calquence

Copiktra

Cotellic

Darzalex

Daurismo

Erivedge

Erleada

Folotyn

Fotivda

Gavreto

Gilotrif

Halaven

Herceptin

Ibrance

Idhifa

Imbruvica

Imfinzi

Inlyta

Inqovi

Inrebic

Iressa

Ixempra

Jakafi

Kadcyla

Koselugo

Lenvima

Lonsurf

Lorbrena

Lumakras

Lynparza

Matulane

Mekinist

Nexavar

Nubeqa

Odomzo

Oncaspar

Onureg

Opdivo

Orgovyx

Piqray

Qinlock

retevmo

Revlimid

Rituxan

Rozlytrek

Rubraca

Stivarga

Sutent

Tabrecta

Tafinlar

Tagrisso

Talzenna

Tarceva

Targretin

Tasigna

Tazverik

Tibsovo

Treanda

Tykerb

Venclexta

Verzenio

Vitravki

Vizimpro

Votrient

Xalkori

Xospata

Xpovio

Xtandi

Yervoy

Yonsa

Zejula

Zelboraf

Zydelig

Zykadia

Entyvio | SSM Health Specialty PharmacyLumicera

Which health plans does SSM Health Specialty PharmacyLumicera have contracts with?

Does SSM Health Specialty PharmacyLumicera work closely with Entyvio and Takeda Pharmaceuticals America, Inc.?

Does SSM Health Specialty PharmacyLumicera offer services for Entyvio patients?

What conditions does SSM Health Specialty PharmacyLumicera support?

How does SSM Health Specialty PharmacyLumicera help with insurance?